2022 ASCO Annual Meeting "The Effects of AVM0703 Mobilization of Endogenous γδ Invariant TCR+ Bi-specific NKT-like Cells Against Solid Tumors & Blood Cancers"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

2022 ASCO Annual Meeting "The Effects of AVM0703 Mobilization of Endogenous γδ Invariant TCR+ Bi-specific NKT-like Cells Against Solid Tumors & Blood Cancers"

By ASCO 2022 Conference Coverage FEATURING Jena Dalpez

109 views

July 1, 2022

Dr. Theresa Deisher of AVM Biotechnology provides an explanation of poster #2579 presented at the ...
read more ↘ 2022 ASCO Annual Meeting
↖ read less

0 Comments

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Shingles (Herpes Zoster) Vaccination in Adults: What is the Importan…